NL0006237562 - Common Stock

Overall **ARCAD** gets a fundamental rating of **3** out of 10. We evaluated **ARCAD** against 30 industry peers in the **Professional Services** industry. **ARCAD** has an average financial health and profitability rating. **ARCAD** does not seem to be growing, but still is valued expensively.

In the past year **ARCAD** had a positive cash flow from operations.

In the past 5 years **ARCAD** has always been profitable.

In the past 5 years **ARCAD** always reported a positive cash flow from operatings.

The **Average Return On Invested Capital** over the past 3 years for **ARCAD** is below the industry average of **11.78%**.

The last **Return On Invested Capital** (**9.25%**) for **ARCAD** is above the 3 year average (**9.02%**), which is a sign of increasing profitability.

Industry Rank | Sector Rank | ||
---|---|---|---|

ROA | 4.23% | ||

ROE | 15.04% | ||

ROIC | 9.25% |

ROA(3y)4.6%

ROA(5y)2.98%

ROE(3y)14.89%

ROE(5y)9.62%

ROIC(3y)9.02%

ROIC(5y)8.59%

In the last couple of years the **Profit Margin** of **ARCAD** has grown nicely.

Looking at the **Operating Margin**, with a value of **8.06%**, **ARCAD** is in the better half of the industry, outperforming **66.67%** of the companies in the same industry.

Industry Rank | Sector Rank | ||
---|---|---|---|

OM | 8.06% | ||

PM (TTM) | 4.26% | ||

GM | N/A |

OM growth 3Y0.26%

OM growth 5Y7.36%

PM growth 3Y77.81%

PM growth 5YN/A

GM growth 3YN/A

GM growth 5YN/A

The Return on Invested Capital (ROIC) is just above the Cost of Capital (WACC), so **ARCAD** is still creating some value.

The number of shares outstanding for **ARCAD** has been increased compared to 1 year ago.

The number of shares outstanding for **ARCAD** has been increased compared to 5 years ago.

Compared to 1 year ago, **ARCAD** has an improved debt to assets ratio.

Looking at the **Altman-Z score**, with a value of **2.92**, **ARCAD** is in line with its industry, outperforming **48.15%** of the companies in the same industry.

A Debt/Equity ratio of **1.03** is on the high side and indicates that **ARCAD** has dependencies on debt financing.

Industry Rank | Sector Rank | ||
---|---|---|---|

Debt/Equity | 1.03 | ||

Debt/FCF | 4.34 | ||

Altman-Z | 2.92 |

ROIC/WACC1.4

WACC6.61%

A Current Ratio of **1.20** indicates that **ARCAD** should not have too much problems paying its short term obligations.

A Quick Ratio of **1.20** indicates that **ARCAD** should not have too much problems paying its short term obligations.

Industry Rank | Sector Rank | ||
---|---|---|---|

Current Ratio | 1.2 | ||

Quick Ratio | 1.2 |

The **Earnings Per Share** has been growing slightly by **3.36%** over the past year.

Looking at the last year, **ARCAD** shows a small growth in **Revenue**. The Revenue has grown by **0.76%** in the last year.

EPS 1Y (TTM)3.36%

EPS 3YN/A

EPS 5YN/A

EPS Q2Q%N/A

Revenue 1Y (TTM)0.76%

Revenue growth 3YN/A

Revenue growth 5YN/A

Sales Q2Q%N/A

Based on estimates for the next years, **ARCAD** will show a decrease in **Earnings Per Share**. The EPS will decrease by **-5.28%** on average per year.

The **Revenue** is expected to grow by **4.52%** on average over the next years.

EPS Next Y9.71%

EPS Next 2Y5.64%

EPS Next 3Y-7.26%

EPS Next 5Y-5.28%

Revenue Next Year1.48%

Revenue Next 2Y15.79%

Revenue Next 3Y8.76%

Revenue Next 5Y4.52%

With a **Price/Earnings** ratio of **41.43**, **ARCAD** can be considered very expensive at the moment.

Compared to the rest of the industry, the **Price/Earnings** ratio of **ARCAD** indicates a slightly more expensive valuation: **ARCAD** is more expensive than 74.07% of the companies listed in the same industry.

The average S&P500 **Price/Earnings** ratio is at **28.86**. **ARCAD** is valued slightly more expensive when compared to this.

The **Price/Forward Earnings** ratio is **37.12**, which means the current valuation is very expensive for **ARCAD**.

Compared to the rest of the industry, the **Price/Forward Earnings** ratio of **ARCAD** indicates a slightly more expensive valuation: **ARCAD** is more expensive than 74.07% of the companies listed in the same industry.

When comparing the **Price/Forward Earnings** ratio of **ARCAD** to the average of the S&P500 Index (**20.69**), we can say **ARCAD** is valued expensively.

Industry Rank | Sector Rank | ||
---|---|---|---|

PE | 41.43 | ||

Fwd PE | 37.12 |

The rest of the industry has a similar **Price/Free Cash Flow** ratio as **ARCAD**.

Industry Rank | Sector Rank | ||
---|---|---|---|

P/FCF | 21.41 | ||

EV/EBITDA | 13.8 |

The high **PEG Ratio(NY)**, which compensates the Price/Earnings for growth, indicates **ARCAD** does not grow enough to justify the current Price/Earnings ratio.

A cheap valuation may be justified as **ARCAD**'s earnings are expected to decrease with **-7.26%** in the coming years.

PEG (NY)4.27

PEG (5Y)N/A

EPS Next 2Y5.64%

EPS Next 3Y-7.26%

Compared to an average industry **Dividend Yield** of **2.60**, **ARCAD** has a dividend in line with its industry peers.

With a **Dividend Yield** of **1.36**, **ARCAD** pays less dividend than the S&P500 average, which is at **2.29**.

Industry Rank | Sector Rank | ||
---|---|---|---|

Dividend Yield | 1.36% |

The dividend of **ARCAD** is nicely growing with an annual growth rate of **35.08%**!

Dividend Growth(5Y)35.08%

Div Incr Years5

Div Non Decr Years5

DP41.41%

EPS Next 2Y5.64%

EPS Next 3Y-7.26%

**ARCADIS NV**

AMS:ARCAD (7/24/2024, 2:56:25 PM)

**63.8**

**+0.25 (+0.39%) **

Chartmill FA Rating

GICS SectorIndustrials

GICS IndustryGroupCommercial & Professional Services

GICS IndustryProfessional Services

Earnings (Last)

Earnings (Next)

Inst Owners

Inst Owner Change

Ins Owners

Ins Owner Change

Market Cap5.74B

Analysts

Price Target

Dividend

Industry Rank | Sector Rank | ||
---|---|---|---|

Dividend Yield | 1.36% |

Dividend Growth(5Y)

DP

Div Incr Years

Div Non Decr Years

Ex-Date

Surprises & Revisions

EPS beat(2)

Avg EPS beat(2)

Min EPS beat(2)

Max EPS beat(2)

EPS beat(4)

Avg EPS beat(4)

Min EPS beat(4)

Max EPS beat(4)

EPS beat(8)

Avg EPS beat(8)

EPS beat(12)

Avg EPS beat(12)

EPS beat(16)

Avg EPS beat(16)

Revenue beat(2)

Avg Revenue beat(2)

Min Revenue beat(2)

Max Revenue beat(2)

Revenue beat(4)

Avg Revenue beat(4)

Min Revenue beat(4)

Max Revenue beat(4)

Revenue beat(8)

Avg Revenue beat(8)

Revenue beat(12)

Avg Revenue beat(12)

Revenue beat(16)

Avg Revenue beat(16)

PT rev (1m)

PT rev (3m)

EPS NQ rev (1m)

EPS NQ rev (3m)

EPS NY rev (1m)

EPS NY rev (3m)

Revenue NQ rev (1m)

Revenue NQ rev (3m)

Revenue NY rev (1m)

Revenue NY rev (3m)

Valuation

Industry Rank | Sector Rank | ||
---|---|---|---|

PE | 41.43 | ||

Fwd PE | 37.12 | ||

P/S | |||

P/FCF | |||

P/OCF | |||

P/B | |||

P/tB | |||

EV/EBITDA |

EPS(TTM)

EY

EPS(NY)

Fwd EY

FCF(TTM)

FCFY

OCF(TTM)

OCFY

SpS

BVpS

TBVpS

PEG (NY)4.27

PEG (5Y)N/A

Profitability

Industry Rank | Sector Rank | ||
---|---|---|---|

ROA | 4.23% | ||

ROE | 15.04% | ||

ROCE | |||

ROIC | |||

ROICexc | |||

ROICexgc | |||

OM | 8.06% | ||

PM (TTM) | 4.26% | ||

GM | N/A | ||

FCFM |

ROA(3y)

ROA(5y)

ROE(3y)

ROE(5y)

ROIC(3y)

ROIC(5y)

ROICexc(3y)

ROICexc(5y)

ROICexgc(3y)

ROICexgc(5y)

ROCE(3y)

ROCE(5y)

ROICexcg growth 3Y

ROICexcg growth 5Y

ROICexc growth 3Y

ROICexc growth 5Y

OM growth 3Y

OM growth 5Y

PM growth 3Y

PM growth 5Y

GM growth 3Y

GM growth 5Y

F-Score

Asset Turnover0.99

Health

Industry Rank | Sector Rank | ||
---|---|---|---|

Debt/Equity | 1.03 | ||

Debt/FCF | |||

Debt/EBITDA | |||

Cap/Depr | |||

Cap/Sales | |||

Interest Coverage | |||

Cash Conversion | |||

Profit Quality | |||

Current Ratio | 1.2 | ||

Quick Ratio | 1.2 | ||

Altman-Z |

F-Score

WACC

ROIC/WACC

Cap/Depr(3y)

Cap/Depr(5y)

Cap/Sales(3y)

Cap/Sales(5y)

Profit Quality(3y)

Profit Quality(5y)

High Growth Momentum

Growth

EPS 1Y (TTM)3.36%

EPS 3YN/A

EPS 5Y

EPS Q2Q%

EPS Next Y9.71%

EPS Next 2Y

EPS Next 3Y

EPS Next 5Y

Revenue 1Y (TTM)0.76%

Revenue growth 3YN/A

Revenue growth 5Y

Sales Q2Q%

Revenue Next Year

Revenue Next 2Y

Revenue Next 3Y

Revenue Next 5Y

EBIT growth 1Y

EBIT growth 3Y

EBIT growth 5Y

EBIT Next Year

EBIT Next 3Y

EBIT Next 5Y

FCF growth 1Y

FCF growth 3Y

FCF growth 5Y

OCF growth 1Y

OCF growth 3Y

OCF growth 5Y